[1]
Mamun, S.A.A., Jahan, R., Islam, Q.T., Nazrin, T. and Shajalal, K. 2021. Rationale of Using Common Antifibrotic Therapy in Post COVID Fibrosis. Journal of Medicine. 22, 1 (Jan. 2021), 46–50. DOI:https://doi.org/10.3329/jom.v22i1.51391.